Nanomed Devices, Inc., founded in 2005, incorporated in Delaware, and based in Albany, NY, is a clinical-stage medical product company focusing on developing and commercializing non-invasive drug delivery technology. Nanomed's transdermal device technology is designed to safely and more effectively deliver drugs, including protein drugs that, until now, must be delivered by needle injection. It has a fully owned subsidiary in China where Nanomed has established high-quality, low-cost product development and manufacturing capability.